3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Recruiting
3
Sponsor Class
INDUSTRY
7
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
3
Sarcoma
1
Gynecologic
1
Conditions
Breast Neoplasms
2
Advanced Breast Cancer
1
Interventions
Cyclophosphamide
423
Trastuzumab
414
Paclitaxel
375
Docetaxel
314
Capecitabine
265
Letrozole
262
Carboplatin
257
Doxorubicin
213
Tamoxifen
184
Fulvestrant
176
Epirubicin
176
Radiotherapy
171
Anastrozole
164
pembrolizumab
152
pertuzumab
147
Surveys and Questionnaires
145
Exercise
142
exemestane
128
Vinorelbine
127
palbociclib
124
Bevacizumab
123
Magnetic Resonance Spectroscopy
120
Blood Specimen Collection
120
Drug Therapy
106
Albumin-Bound Paclitaxel
105
Gemcitabine
99
130-nm albumin-bound paclitaxel
98
pyrotinib
92
eribulin
90
Biopsy
88
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
RAD1901
×
Breast
×
Clear all
NCT07198724
2026-04-09
ERADICATE
Dana-Farber Cancer Institute
Phase 1/2
Recruiting
65 enrolled
NCT06382948
2026-04-03
ADELA
MedSIR
Phase 3
Recruiting
240 enrolled
NCT07222215
2026-01-22
CAPELA
Dana-Farber Cancer Institute
Phase 2
Recruiting
297 enrolled